Home › Funds › Charles Schwab Investment Management › REGN
Charles Schwab Investment Management position in REGN
REGENERON PHARMACEUTICALS INC. · Health Care
Latest position (Q2 2026)846.31K sh
Reported value held$527.71M
Portfolio Weight0.07%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 529.53K | $320.46M | New |
| Q4 2021 | 556.29K | $351.31M | Add |
| Q1 2022 | 562.14K | $392.61M | Add |
| Q2 2022 | 570.46K | $337.22M | Add |
| Q3 2022 | 573.00K | $394.73M | Hold |
| Q4 2022 | 586.94K | $423.47M | Add |
| Q1 2023 | 595.60K | $489.39M | Add |
| Q2 2023 | 600.04K | $431.15M | Add |
| Q3 2023 | 598.06K | $492.18M | Hold |
| Q4 2023 | 620.62K | $545.08M | Add |
| Q1 2024 | 638.22K | $614.28M | Add |
| Q2 2024 | 661.76K | $695.53M | Add |
| Q3 2024 | 673.26K | $707.76M | Add |
| Q4 2024 | 695.80K | $495.64M | Add |
| Q1 2025 | 710.34K | $450.52M | Add |
| Q2 2025 | 720.27K | $378.14M | Add |
| Q3 2025 | 755.57K | $424.83M | Add |
| Q4 2025 | 778.00K | $600.52M | Add |
| Q1 2026 | 804.51K | $621.60M | Add |
| Q2 2026 | 846.31K | $527.71M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026
- Morgan Stanley 1.40M sh · $871.53M · Q2 2026
- Goldman Sachs Group 1.33M sh · $831.98M · Q2 2026
- Bank of America Corp 1.29M sh · $805.02M · Q2 2026
- Wellington Management Group 1.27M sh · $791.95M · Q2 2026
- Norges Bank Investment Management 1.17M sh · $731.29M · Q2 2026